These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 1287276

  • 1. Calcium channel blocker-like action of 1,9-dideoxyforskolin in vascular smooth muscle.
    Abe A, Karaki H.
    Jpn J Pharmacol; 1992 Dec; 60(4):389-92. PubMed ID: 1287276
    [Abstract] [Full Text] [Related]

  • 2. Effects of a novel smooth muscle relaxant, KT-362, on contraction and cytosolic Ca2+ level in the rat aorta.
    Sakata K, Karaki H.
    Br J Pharmacol; 1991 Jan; 102(1):174-8. PubMed ID: 1710524
    [Abstract] [Full Text] [Related]

  • 3. Inhibitory effects of forskolin on vascular smooth muscle of rabbit aorta.
    Abe A, Karaki H.
    Jpn J Pharmacol; 1988 Mar; 46(3):293-301. PubMed ID: 2837603
    [Abstract] [Full Text] [Related]

  • 4. Effects of felodipine, nifedipine and verapamil on cytosolic Ca2+ and contraction in vascular smooth muscle.
    Hagiwara S, Mitsui M, Karaki H.
    Eur J Pharmacol; 1993 Mar 30; 234(1):1-7. PubMed ID: 7682512
    [Abstract] [Full Text] [Related]

  • 5. Calcium channel blocker-like action of reserpine in smooth muscle.
    Satoh T, Moriyama T, Kuriki H, Karaki H.
    Jpn J Pharmacol; 1992 Nov 30; 60(3):291-3. PubMed ID: 1283423
    [Abstract] [Full Text] [Related]

  • 6. Effects of semotiadil fumarate (SD-3211) and its enantiomer, SD-3212, on the changes in cytosolic Ca2+ and tension caused by KCl and norepinephrine in isolated rat aortas.
    Murakami K, Shindo K, Ito KM, Ito K.
    J Cardiovasc Pharmacol; 1995 Feb 30; 25(2):262-7. PubMed ID: 7752651
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibitory effect of 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate (TMB-8) in vascular smooth muscle.
    Ishihara H, Karaki H.
    Eur J Pharmacol; 1991 May 17; 197(2-3):181-6. PubMed ID: 1915568
    [Abstract] [Full Text] [Related]

  • 9. Effects of glibenclamide on cytosolic calcium concentrations and on contraction of the rabbit aorta.
    Yoshitake K, Hirano K, Kanaide H.
    Br J Pharmacol; 1991 Jan 17; 102(1):113-8. PubMed ID: 1904292
    [Abstract] [Full Text] [Related]

  • 10. Different effects of verapamil on cytosolic Ca2+ and contraction in norepinephrine-stimulated vascular smooth muscle.
    Karaki H, Sato K, Ozaki H.
    Jpn J Pharmacol; 1991 Jan 17; 55(1):35-42. PubMed ID: 2041228
    [Abstract] [Full Text] [Related]

  • 11. Effect of forskolin on cytosolic Ca++ level and contraction in vascular smooth muscle.
    Abe A, Karaki H.
    J Pharmacol Exp Ther; 1989 Jun 17; 249(3):895-900. PubMed ID: 2732951
    [Abstract] [Full Text] [Related]

  • 12. Mechanisms underlying the inhibitory effect of dibutyryl cyclic AMP in vascular smooth muscle.
    Abe A, Karaki H.
    Eur J Pharmacol; 1992 Feb 18; 211(3):305-11. PubMed ID: 1319910
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effects of cadralazine and its metabolite, ISF-2405, on contractions and the level of cytosolic Ca2+ in vascular smooth muscle.
    Mitsui M, Nakao K, Inukai T, Karaki H.
    Eur J Pharmacol; 1990 Mar 20; 178(2):171-7. PubMed ID: 2328760
    [Abstract] [Full Text] [Related]

  • 14. Inhibitory effects of caffeine on contractions and calcium movement in vascular and intestinal smooth muscle.
    Ahn HY, Karaki H, Urakawa N.
    Br J Pharmacol; 1988 Feb 20; 93(2):267-74. PubMed ID: 2451962
    [Abstract] [Full Text] [Related]

  • 15. Cicletanine-induced decreases in cytosolic Ca2+ level and contraction in vascular smooth muscle.
    Izumi M, Mitsui-Saito M, Ozaki H, Karaki H.
    Jpn J Pharmacol; 1998 Jan 20; 76(1):57-63. PubMed ID: 9517405
    [Abstract] [Full Text] [Related]

  • 16. Effects of the calcium channel facilitator, CGP 28,392, on different modes of contraction in smooth muscle of rabbit and rat aortae and guinea-pig taenia caeci.
    Karaki H, Nagase H, Ozaki H, Urakawa N, Weiss GB.
    Br J Pharmacol; 1986 Oct 20; 89(2):423-9. PubMed ID: 3779218
    [Abstract] [Full Text] [Related]

  • 17. Effects of LP-805, a new vasodilating agent, on cytosolic Ca2+ and contraction in vascular smooth muscle of rat aorta.
    Kishii K, Inazu M, Morimoto T, Tsujitani M, Takayanagi I.
    Gen Pharmacol; 1992 May 20; 23(3):355-63. PubMed ID: 1511847
    [Abstract] [Full Text] [Related]

  • 18. Dibutyryl cyclic AMP and forskolin inhibit phosphatidylinositol hydrolysis, Ca2+ influx and contraction in vascular smooth muscle.
    Ahn HY, Kang SE, Chang KC, Karaki H.
    Jpn J Pharmacol; 1992 Jun 20; 59(2):263-5. PubMed ID: 1331585
    [Abstract] [Full Text] [Related]

  • 19. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
    Flaim SF, Gleason MM, Hedberg A, Shank RP, McCullough JR, Gill A, Damiano BP, Brannan MD, Carson JR.
    J Pharmacol Exp Ther; 1991 Jan 20; 256(1):279-88. PubMed ID: 1846419
    [Abstract] [Full Text] [Related]

  • 20. The effects of a novel vasodilator, LP-805, on cytosolic Ca2+ concentrations and on tension in rabbit isolated femoral arteries.
    Ushio-Fukai M, Hirano K, Kanaide H.
    Br J Pharmacol; 1994 Dec 20; 113(4):1173-82. PubMed ID: 7889270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.